Two failed IVF cycles. Three. Sometimes four. Each one with good embryos, a cooperative uterine lining, and no clear answer from the clinic about why it is not working. For thousands of couples worldwide, this is the exhausting reality of recurrent IVF failure. What most are never told is that the male partner is a contributing factor in a significant number of these cases, and that a routine semen analysis, the standard test almost every clinic runs, is not equipped to find it. The conditions that cause repeated cycle failure in men are specific, diagnosable, and in most cases treatable. This guide covers exactly what those conditions are, which male infertility treatments actually change outcomes, and why IVF treatment in India is where many international couples are finally finding the answers they need.
The Test That Misses the Problem
A semen analysis measures three things: how many sperm are present, how many are moving, and broadly what shape they are. For decades, a normal result on these three parameters meant the male partner was cleared and investigation stopped there.
The problem is that sperm can look completely normal under a microscope while carrying severely damaged genetic material. That damage, called sperm DNA fragmentation, does not show up on a semen analysis at all. A man can have a perfect semen report and still have sperm that fertilise an egg but prevent the resulting embryo from developing to a viable stage.
What the Research Confirms
High sperm DNA fragmentation is directly linked to poor embryo quality, recurrent implantation failure, and early pregnancy loss. Research published in PMC (PMC5137216) confirms that elevated sperm DNA fragmentation is associated with adverse reproductive outcomes in IVF and ICSI cycles, and that an elevated sperm DNA fragmentation rate in couples with recurrent ART failure may point to a paternal cause even when semen parameters are normal.
A separate 2019 study from Weill Cornell Medicine (PMC6823295) found that up to 11 percent of men with a completely normal semen analysis carry a noticeable degree of sperm chromatin fragmentation, enough to affect IVF outcomes without ever triggering a red flag on standard testing.
The 2024 AUA and ASRM Male Infertility Guideline states specifically that in couples with two or more failed assisted reproductive technology cycles, the male partner should be evaluated by a reproductive specialist, and sperm DNA fragmentation testing should be considered. This step is still skipped at many clinics.
Male Conditions That Drive Recurrent IVF Failure
Once the right tests are done, a number of specific male-factor conditions emerge as the actual cause behind repeated cycle failures.
Sperm DNA Fragmentation
As covered above, this is the most common overlooked cause. A DNA Fragmentation Index (DFI) above 25 to 30 percent is considered elevated. Research from a 2015 NIH study (PMC4617559) confirms that high DFI is associated with recurrent pregnancy loss, recurrent IVF failure, and increased congenital abnormalities. Unlike semen count or motility, DFI requires a separate, dedicated test.
Varicocele
Varicocele is an enlargement of the veins inside the scrotum that raises scrotal temperature and increases oxidative damage to sperm DNA. It is found in approximately 40 percent of infertile men and is the most commonly correctable cause of male infertility. Many men with varicocele produce sperm that appears statistically normal on analysis, yet carries elevated fragmentation and poor genetic integrity that quietly undermines every IVF cycle.
Azoospermia
Azoospermia means no sperm is found in the ejaculate. For many couples this feels like the end of the road, but it frequently is not. Obstructive azoospermia, where sperm is produced normally but physically blocked from reaching the ejaculate, can be resolved through surgical sperm retrieval. Non-obstructive azoospermia, where production itself is impaired, can also yield viable sperm through advanced microsurgical techniques in a significant number of cases.
Hormonal Imbalances
Low testosterone, elevated prolactin, and abnormal FSH or LH levels can all reduce sperm production quality without obvious symptoms. A full hormone panel takes a few hours and can identify the exact endocrine disruption driving poor sperm function, with targeted treatment available once the cause is confirmed.
Sperm Aneuploidy
Some men produce sperm that carry an incorrect number of chromosomes, a condition called sperm aneuploidy. These sperm can fertilise eggs and produce embryos that look viable on day three or five but fail to implant or result in very early miscarriage. Fluorescence in situ hybridisation (FISH) testing can identify this condition and guide the decision to combine ICSI with Preimplantation Genetic Testing.
Male Infertility Treatment Options That Change IVF Outcomes
Each of the conditions above has a targeted treatment path. The key is accurate diagnosis first.
Sperm DNA Fragmentation Testing and Reduction
DFI testing costs approximately Rs. 5,000 to Rs. 10,000 in India. Based on results, treatment takes one of two directions.
Read: https://artfertilityclinics.in/blog/sperm-dna-fragmentation-dfi-test-a-fertility-check
For mild to moderate fragmentation, a structured antioxidant protocol using vitamins C and E, CoQ10, and zinc, combined with dietary changes and avoidance of heat sources, can reduce DFI meaningfully within 60 to 90 days. This is done before the next IVF cycle begins.
For high fragmentation in ejaculated sperm, testicular sperm retrieval is the better solution. Research published in the journal Andrology (2025) found that testicular sperm ICSI cycles yielded significantly higher clinical pregnancy rates and cumulative live birth rates than ejaculated sperm ICSI cycles in couples with recurrent ICSI failure. Testicular sperm consistently carries lower DNA fragmentation than ejaculated sperm from the same man, making TESA combined with ICSI a powerful correction for this group.
ICSI
Intracytoplasmic Sperm Injection involves an embryologist selecting a single sperm and injecting it directly into the egg, bypassing the need for sperm to penetrate the egg independently. ICSI achieves fertilisation rates of 70 to 80 percent, compared to 50 to 60 percent with standard IVF. For any couple where male factor is present or suspected, ICSI is not an upgrade. It is the standard of care.
A complete ICSI cycle as part of IVF treatment in India costs between Rs. 1,50,000 and Rs. 2,50,000, inclusive of the procedure. That is 70 to 80 percent less than equivalent treatment in the UK, USA, or most of Europe.
PICSI
Physiological ICSI adds a biological selection layer on top of visual sperm selection. Mature, genetically intact sperm bind naturally to hyaluronic acid. PICSI uses this property to select only sperm with higher structural and genetic integrity before injection. A published case study (PMC10918439) confirmed that PICSI resolved secondary infertility caused by sperm DNA fragmentation where ICSI alone had previously failed.
IMSI
Intracytoplasmic Morphologically Selected Sperm Injection uses digital imaging at up to 6,000x magnification, roughly 15 times greater than standard ICSI, to identify and exclude sperm with subtle internal structural abnormalities that are invisible at normal microscopy. IMSI is specifically indicated for couples with repeated IVF failure and poor embryo quality, where the cause may lie in sperm morphology that standard selection techniques cannot detect.
TESA, PESA, and Micro-TESE
For men with azoospermia or high ejaculated sperm DFI, sperm is retrieved surgically directly from the reproductive tract.
TESA (Testicular Sperm Aspiration) uses a fine needle to extract sperm from the testis and costs approximately Rs. 40,000 to Rs. 60,000 in India. PESA (Percutaneous Epididymal Sperm Aspiration) retrieves from the epididymis and costs Rs. 50,000 to Rs. 80,000. For non-obstructive azoospermia, Micro-TESE uses a surgical microscope to locate the small pockets of testicular tissue where sperm production still occurs, even when standard biopsy finds nothing. It is the most advanced sperm retrieval technique available and is offered at top NABH-accredited fertility hospitals in India.
Retrieved sperm is used immediately with ICSI on the same day as egg retrieval, or cryopreserved for future cycles.
Varicocele Repair
Surgical correction of varicocele (varicocelectomy) performed three to six months before an IVF cycle can significantly improve sperm count, motility, and DNA integrity. Couples who address varicocele before the next cycle start with a genuinely better baseline, rather than repeating the same cycle with the same underlying impairment in place.
Preimplantation Genetic Testing (PGT)
When sperm chromosomal abnormalities such as aneuploidy are identified, PGT allows embryos to be tested before transfer. Only chromosomally normal embryos are transferred, substantially improving implantation rates and reducing miscarriage risk. PGT combined with ICSI is the most targeted response available when a genetic sperm factor is driving repeated failure.
Why IVF Treatment in India Is the Right Move for This Specific Journey
The combination of advanced male infertility workup and full IVF cycle management is exactly where India's top fertility centres excel, and where the cost difference is most significant for international couples.
The Full Workup Is Done Concurrently
At leading fertility hospitals in India, the male partner's sperm DNA fragmentation testing, hormone panel, and scrotal ultrasound are conducted simultaneously with the female partner's evaluation from the very first consultation. This parallel approach, which saves months of misdirected treatment, is not standard everywhere. Many couples arrive in India after spending a year treating only the woman, when a simple DFI test at the start would have changed their entire treatment direction.
Cost Savings Are Substantial
A full IVF treatment in India including ICSI runs between Rs. 1,50,000 and Rs. 3,00,000 per cycle (approximately USD 1,800 to 3,600). Advanced add-ons including TESA, PICSI, or PGT raise the total, but the combined package still comes in at a fraction of what a single cycle costs in the UK or USA. For couples who have already spent heavily on failed cycles abroad, India represents a medically credible second chance that does not require compromising on the quality of care.
NABH-Accredited Hospitals with Full Andrology Capability
Karetrip's partner fertility hospitals are NABH-accredited and offer the complete spectrum of advanced male infertility treatments including ICSI, IMSI, PICSI, TESA, PESA, Micro-TESE, and PGT under one roof, with dedicated andrology laboratories staffed by trained embryologists.
Leading IVF and Fertility Centers in India Linked with Karetrip
To ensure international couples receive the absolute highest standards of reproductive medicine, Karetrip partners exclusively with premier, high-success fertility institutions across India. These fully accredited centers combine world-class embryology laboratories with advanced genetic and male-factor diagnostic screenings.
Our network of specialized IVF hospitals includes:
-
Chennai Fertility Centre: Renowned globally for handling highly complex, multi-cycle failure cases, this center features a state-of-the-art embryology suite and specializes in advanced male factor interventions like IMSI and micro-TESE. Its exceptionally high clinical success rates make it a primary destination for international couples seeking definitive answers.
-
Nova IVF Fertility Center, Kolkata: This premium facility brings standardized, internationally benchmarked IVF protocols to Eastern India, offering cutting-edge pre-implantation genetic testing (PGT) alongside comprehensive fertility monitoring. It is highly sought after for its transparent, evidence-based treatment plans and compassionate international patient care.
-
Nova IVF Fertility Center, Delhi: Located in India's capital city, this flagship center integrates sophisticated diagnostic machinery with advanced artificial intelligence embryology tracking to maximize embryo selection precision. It offers highly streamlined logistics and rapid medical-visa treatment processing for global patients.
-
Prashanth Fertility Research Center: A legendary institution in reproductive health, PFRC combines decades of pioneering clinical research with full-spectrum reproductive surgeries under one roof. It is a premier choice for couples requiring complex reproductive endoscopy or advanced cryopreservation techniques.
-
Apollo Gleneagles Hospital, Kolkata: Operating within a massive, JCI-accredited multi-specialty framework, this center provides unparalleled safety for high-risk pregnancies or couples with co-existing maternal medical complications. It ensures seamless, multi-disciplinary backup from global endocrinologists, cardiologists, and advanced neonatologists.
-
Jeevan Mitra Fertility Centre: Celebrated for its highly customized, boutique approach to reproductive medicine, this center excels in tailored low-ovarian-reserve protocols and intensive DNA Fragmentation Index (DFI) screening for severe male infertility. It offers affordable, high-quality care with an intimate, deeply supportive patient experience.
How Karetrip Supports Your Fertility Journey in India
Karetrip works with India's top NABH-accredited fertility centres to give international couples access to the full range of advanced male infertility treatments alongside complete IVF cycle management. From arranging your initial specialist consultation and coordinating DFI testing for the male partner, to managing your medical visa, accommodation near the hospital, and remote follow-up from home after treatment, every part of the journey is handled by a dedicated coordinator who speaks your language and understands your situation.
Couples from Nigeria, Bangladesh, Kenya, the UAE, and the UK have reached the right diagnosis and the right treatment through Karetrip, often after years of failed cycles with no clear explanation.
Chat with our Medical care assistant, RUA, for quick guidance and support and find out whether an unaddressed male factor is behind your repeated IVF failures.
Medical Disclaimer
This article is for general educational and awareness purposes only. It does not constitute or replace professional medical advice, diagnosis, or treatment by a qualified fertility specialist or andrologist. Individual IVF and male infertility treatment outcomes vary based on unique clinical profiles. Always consult a specialized physician before making medical decisions.